Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM): Results of the feasibility
trial Diabetes Care August 1995 18:1113-1123; doi:10.2337/diacare.18.8.1113
Comparison of Bedtime NPH or Preprandial Regular Insulin Combined With Glibenclamide in Secondary Sulfonylurea Failure Diabetes Care August 1995 18:1183-1186; doi:10.2337/diacare.18.8.1183
Reproducibility of the First-Phase Insulin Response to Intravenous Glucose Is Not Improved by Retrograde Cannulation and Arterialization
or the Use of a Lower Glucose Dose Diabetes Care August 1995 18:1168-1173; doi:10.2337/diacare.18.8.1168
Grapefruit Juice in Alloxan-Induced Diabetes in Rabbits Diabetes Care August 1995 18:1199; doi:10.2337/diacare.18.8.1199a
Arai, Katsumi
1,5-Anhydro-D-glucitol Evaluates Daily Glycemic Excursions in Well-Controlled NIDDM Diabetes Care August 1995 18:1156-1159; doi:10.2337/diacare.18.8.1156
Comparison of Bedtime NPH or Preprandial Regular Insulin Combined With Glibenclamide in Secondary Sulfonylurea Failure Diabetes Care August 1995 18:1183-1186; doi:10.2337/diacare.18.8.1183
Exocrine Pancreatic and β-cell Function in Malnutrition-Related Diabetes Among North Indians Diabetes Care August 1995 18:1174-1178; doi:10.2337/diacare.18.8.1174
Exocrine Pancreatic and β-cell Function in Malnutrition-Related Diabetes Among North Indians Diabetes Care August 1995 18:1174-1178; doi:10.2337/diacare.18.8.1174
American Diabetes Association Scientific Sessions, 1995: Non-insulin-dependent diabetes mellitus Diabetes Care August 1995 18:1215-1219; doi:10.2337/diacare.18.8.1215
Bolinder, Jan
Comparison of Bedtime NPH or Preprandial Regular Insulin Combined With Glibenclamide in Secondary Sulfonylurea Failure Diabetes Care August 1995 18:1183-1186; doi:10.2337/diacare.18.8.1183
Lipoprotein(a), Apolipoprotein(a) Polymorphism, and Insulin Treatment in Type II Diabetic Patients Diabetes Care August 1995 18:1202-1203; doi:10.2337/diacare.18.8.1202
Braimon, Jennifer
Local Reaction Secondary to Insulin Injection: A potential role for latex antigens in insulin vials and syringes Diabetes Care August 1995 18:1195-1197; doi:10.2337/diacare.18.8.1195
Lipoprotein(a), Apolipoprotein(a) Polymorphism, and Insulin Treatment in Type II Diabetic Patients Diabetes Care August 1995 18:1202-1203; doi:10.2337/diacare.18.8.1202
Butkiewicz, Eryn K
Insulin Therapy for Diabetic Ketoacidosis: Bolus insulin injection versus continuous insulin infusion Diabetes Care August 1995 18:1187-1190; doi:10.2337/diacare.18.8.1187
Effects of Alprazolam on Glucose Regulation in Diabetes: Results of double-blind, placebo-controlled trial Diabetes Care August 1995 18:1133-1139; doi:10.2337/diacare.18.8.1133
Serum Lipids and Lipoprotein(a) Concentrations in Chinese NIDDM Patients: Relation to metabolic control Diabetes Care August 1995 18:1191-1194; doi:10.2337/diacare.18.8.1191
Exocrine Pancreatic and β-cell Function in Malnutrition-Related Diabetes Among North Indians Diabetes Care August 1995 18:1174-1178; doi:10.2337/diacare.18.8.1174
Diabetes Self-Management Education Diabetes Care August 1995 18:1204-1214; doi:10.2337/diacare.18.8.1204
Clouse, Ray E
Effects of Alprazolam on Glucose Regulation in Diabetes: Results of double-blind, placebo-controlled trial Diabetes Care August 1995 18:1133-1139; doi:10.2337/diacare.18.8.1133
Reduction of Postprandial Hyperglycemia in Subjects With IDDM by Intravenous Infusion of AC137, a Human Amylin Analogue Diabetes Care August 1995 18:1179-1182; doi:10.2337/diacare.18.8.1179
High Prevalence of Diabetic Retinopathy and Nephropathy in Polynesians of Western Samoa Diabetes Care August 1995 18:1140-1149; doi:10.2337/diacare.18.8.1140
Reproducibility of the First-Phase Insulin Response to Intravenous Glucose Is Not Improved by Retrograde Cannulation and Arterialization
or the Use of a Lower Glucose Dose Diabetes Care August 1995 18:1168-1173; doi:10.2337/diacare.18.8.1168
Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM): Results of the feasibility
trial Diabetes Care August 1995 18:1113-1123; doi:10.2337/diacare.18.8.1113
Release of Platelet Plasminogen Activator Inhibitor 1 in Whole Blood Is Increased in Patients With Type II Diabetes Diabetes Care August 1995 18:1150-1155; doi:10.2337/diacare.18.8.1150
Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM): Results of the feasibility
trial Diabetes Care August 1995 18:1113-1123; doi:10.2337/diacare.18.8.1113
High Prevalence of Diabetic Retinopathy and Nephropathy in Polynesians of Western Samoa Diabetes Care August 1995 18:1140-1149; doi:10.2337/diacare.18.8.1140
Effects of Alprazolam on Glucose Regulation in Diabetes: Results of double-blind, placebo-controlled trial Diabetes Care August 1995 18:1133-1139; doi:10.2337/diacare.18.8.1133
Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM): Results of the feasibility
trial Diabetes Care August 1995 18:1113-1123; doi:10.2337/diacare.18.8.1113
Self-Perceived Stress, Hostility, and Insulin Resistance: Lack of Association Diabetes Care August 1995 18:1198-1199; doi:10.2337/diacare.18.8.1198
Feskens, Edith J
Dietary Factors Determining Diabetes and Impaired Glucose Tolerance: A 20-year follow-up of the Finnish and Dutch cohorts
of the Seven Countries Study Diabetes Care August 1995 18:1104-1112; doi:10.2337/diacare.18.8.1104
Lipoprotein(a), Apolipoprotein(a) Polymorphism, and Insulin Treatment in Type II Diabetic Patients Diabetes Care August 1995 18:1202-1203; doi:10.2337/diacare.18.8.1202
Freedland, Kenneth E
Effects of Alprazolam on Glucose Regulation in Diabetes: Results of double-blind, placebo-controlled trial Diabetes Care August 1995 18:1133-1139; doi:10.2337/diacare.18.8.1133
Lipoprotein(a), Apolipoprotein(a) Polymorphism, and Insulin Treatment in Type II Diabetic Patients Diabetes Care August 1995 18:1202-1203; doi:10.2337/diacare.18.8.1202
Gazzaruso, Carmine
Lipoprotein(a), Apolipoprotein(a) Polymorphism, and Insulin Treatment in Type II Diabetic Patients Diabetes Care August 1995 18:1202-1203; doi:10.2337/diacare.18.8.1202
Geroldi, Diego
Lipoprotein(a), Apolipoprotein(a) Polymorphism, and Insulin Treatment in Type II Diabetic Patients Diabetes Care August 1995 18:1202-1203; doi:10.2337/diacare.18.8.1202
Gottlieb, Alan
Reduction of Postprandial Hyperglycemia in Subjects With IDDM by Intravenous Infusion of AC137, a Human Amylin Analogue Diabetes Care August 1995 18:1179-1182; doi:10.2337/diacare.18.8.1179
Effects of Alprazolam on Glucose Regulation in Diabetes: Results of double-blind, placebo-controlled trial Diabetes Care August 1995 18:1133-1139; doi:10.2337/diacare.18.8.1133
Reproducibility of the First-Phase Insulin Response to Intravenous Glucose Is Not Improved by Retrograde Cannulation and Arterialization
or the Use of a Lower Glucose Dose Diabetes Care August 1995 18:1168-1173; doi:10.2337/diacare.18.8.1168
Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM): Results of the feasibility
trial Diabetes Care August 1995 18:1113-1123; doi:10.2337/diacare.18.8.1113
Accuracy of Self-Monitoring Blood Glucose Meters in a High Humidity, High Temperature Summer Camp Setting Diabetes Care August 1995 18:1200-1201; doi:10.2337/diacare.18.8.1200
I
Imo, Tofaeono T
High Prevalence of Diabetic Retinopathy and Nephropathy in Polynesians of Western Samoa Diabetes Care August 1995 18:1140-1149; doi:10.2337/diacare.18.8.1140
Release of Platelet Plasminogen Activator Inhibitor 1 in Whole Blood Is Increased in Patients With Type II Diabetes Diabetes Care August 1995 18:1150-1155; doi:10.2337/diacare.18.8.1150
1,5-Anhydro-D-glucitol Evaluates Daily Glycemic Excursions in Well-Controlled NIDDM Diabetes Care August 1995 18:1156-1159; doi:10.2337/diacare.18.8.1156
Serum Lipids and Lipoprotein(a) Concentrations in Chinese NIDDM Patients: Relation to metabolic control Diabetes Care August 1995 18:1191-1194; doi:10.2337/diacare.18.8.1191
1,5-Anhydro-D-glucitol Evaluates Daily Glycemic Excursions in Well-Controlled NIDDM Diabetes Care August 1995 18:1156-1159; doi:10.2337/diacare.18.8.1156
1,5-Anhydro-D-glucitol Evaluates Daily Glycemic Excursions in Well-Controlled NIDDM Diabetes Care August 1995 18:1156-1159; doi:10.2337/diacare.18.8.1156
Serial Changes in the Prevalence of Islet Cell Antibodies and Islet Cell Antibody Titer in Children With IDDM of Abrupt or
Slow Onset Diabetes Care August 1995 18:1095-1099; doi:10.2337/diacare.18.8.1095
Release of Platelet Plasminogen Activator Inhibitor 1 in Whole Blood Is Increased in Patients With Type II Diabetes Diabetes Care August 1995 18:1150-1155; doi:10.2337/diacare.18.8.1150
Reduction of Postprandial Hyperglycemia in Subjects With IDDM by Intravenous Infusion of AC137, a Human Amylin Analogue Diabetes Care August 1995 18:1179-1182; doi:10.2337/diacare.18.8.1179
Dietary Factors Determining Diabetes and Impaired Glucose Tolerance: A 20-year follow-up of the Finnish and Dutch cohorts
of the Seven Countries Study Diabetes Care August 1995 18:1104-1112; doi:10.2337/diacare.18.8.1104
Accuracy of Self-Monitoring Blood Glucose Meters in a High Humidity, High Temperature Summer Camp Setting Diabetes Care August 1995 18:1200-1201; doi:10.2337/diacare.18.8.1200
Kubota, Minoru
1,5-Anhydro-D-glucitol Evaluates Daily Glycemic Excursions in Well-Controlled NIDDM Diabetes Care August 1995 18:1156-1159; doi:10.2337/diacare.18.8.1156
Exocrine Pancreatic and β-cell Function in Malnutrition-Related Diabetes Among North Indians Diabetes Care August 1995 18:1174-1178; doi:10.2337/diacare.18.8.1174
Comparison of Bedtime NPH or Preprandial Regular Insulin Combined With Glibenclamide in Secondary Sulfonylurea Failure Diabetes Care August 1995 18:1183-1186; doi:10.2337/diacare.18.8.1183
Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM): Results of the feasibility
trial Diabetes Care August 1995 18:1113-1123; doi:10.2337/diacare.18.8.1113
Insulin Therapy for Diabetic Ketoacidosis: Bolus insulin injection versus continuous insulin infusion Diabetes Care August 1995 18:1187-1190; doi:10.2337/diacare.18.8.1187
Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM): Results of the feasibility
trial Diabetes Care August 1995 18:1113-1123; doi:10.2337/diacare.18.8.1113
Comparison of Bedtime NPH or Preprandial Regular Insulin Combined With Glibenclamide in Secondary Sulfonylurea Failure Diabetes Care August 1995 18:1183-1186; doi:10.2337/diacare.18.8.1183
Release of Platelet Plasminogen Activator Inhibitor 1 in Whole Blood Is Increased in Patients With Type II Diabetes Diabetes Care August 1995 18:1150-1155; doi:10.2337/diacare.18.8.1150
Serum Lipids and Lipoprotein(a) Concentrations in Chinese NIDDM Patients: Relation to metabolic control Diabetes Care August 1995 18:1191-1194; doi:10.2337/diacare.18.8.1191
Effects of Alprazolam on Glucose Regulation in Diabetes: Results of double-blind, placebo-controlled trial Diabetes Care August 1995 18:1133-1139; doi:10.2337/diacare.18.8.1133
Physician and Patient Prevention Practices in NIDDM in a Large Urban Managed-Care Organization Diabetes Care August 1995 18:1124-1132; doi:10.2337/diacare.18.8.1124
Relationship of Low-Density Lipoprotein Particle Size to Plasma Lipoproteins Diabetes Care August 1995 18:1199-1200; doi:10.2337/diacare.18.8.1199b
Matsunaga, Hiroko
Serial Changes in the Prevalence of Islet Cell Antibodies and Islet Cell Antibody Titer in Children With IDDM of Abrupt or
Slow Onset Diabetes Care August 1995 18:1095-1099; doi:10.2337/diacare.18.8.1095
Effects of Alprazolam on Glucose Regulation in Diabetes: Results of double-blind, placebo-controlled trial Diabetes Care August 1995 18:1133-1139; doi:10.2337/diacare.18.8.1133
Reproducibility of the First-Phase Insulin Response to Intravenous Glucose Is Not Improved by Retrograde Cannulation and Arterialization
or the Use of a Lower Glucose Dose Diabetes Care August 1995 18:1168-1173; doi:10.2337/diacare.18.8.1168
Serial Changes in the Prevalence of Islet Cell Antibodies and Islet Cell Antibody Titer in Children With IDDM of Abrupt or
Slow Onset Diabetes Care August 1995 18:1095-1099; doi:10.2337/diacare.18.8.1095
1,5-Anhydro-D-glucitol Evaluates Daily Glycemic Excursions in Well-Controlled NIDDM Diabetes Care August 1995 18:1156-1159; doi:10.2337/diacare.18.8.1156
Local Reaction Secondary to Insulin Injection: A potential role for latex antigens in insulin vials and syringes Diabetes Care August 1995 18:1195-1197; doi:10.2337/diacare.18.8.1195
Reduction of Postprandial Hyperglycemia in Subjects With IDDM by Intravenous Infusion of AC137, a Human Amylin Analogue Diabetes Care August 1995 18:1179-1182; doi:10.2337/diacare.18.8.1179
Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM): Results of the feasibility
trial Diabetes Care August 1995 18:1113-1123; doi:10.2337/diacare.18.8.1113
Dietary Factors Determining Diabetes and Impaired Glucose Tolerance: A 20-year follow-up of the Finnish and Dutch cohorts
of the Seven Countries Study Diabetes Care August 1995 18:1104-1112; doi:10.2337/diacare.18.8.1104
Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM): Results of the feasibility
trial Diabetes Care August 1995 18:1113-1123; doi:10.2337/diacare.18.8.1113
Local Reaction Secondary to Insulin Injection: A potential role for latex antigens in insulin vials and syringes Diabetes Care August 1995 18:1195-1197; doi:10.2337/diacare.18.8.1195
Insulin Therapy for Diabetic Ketoacidosis: Bolus insulin injection versus continuous insulin infusion Diabetes Care August 1995 18:1187-1190; doi:10.2337/diacare.18.8.1187
Serial Changes in the Prevalence of Islet Cell Antibodies and Islet Cell Antibody Titer in Children With IDDM of Abrupt or
Slow Onset Diabetes Care August 1995 18:1095-1099; doi:10.2337/diacare.18.8.1095
Insulin Therapy for Diabetic Ketoacidosis: Bolus insulin injection versus continuous insulin infusion Diabetes Care August 1995 18:1187-1190; doi:10.2337/diacare.18.8.1187
Dietary Factors Determining Diabetes and Impaired Glucose Tolerance: A 20-year follow-up of the Finnish and Dutch cohorts
of the Seven Countries Study Diabetes Care August 1995 18:1104-1112; doi:10.2337/diacare.18.8.1104
High Prevalence of Diabetic Retinopathy and Nephropathy in Polynesians of Western Samoa Diabetes Care August 1995 18:1140-1149; doi:10.2337/diacare.18.8.1140
Dietary Factors Determining Diabetes and Impaired Glucose Tolerance: A 20-year follow-up of the Finnish and Dutch cohorts
of the Seven Countries Study Diabetes Care August 1995 18:1104-1112; doi:10.2337/diacare.18.8.1104
Insulin Therapy for Diabetic Ketoacidosis: Bolus insulin injection versus continuous insulin infusion Diabetes Care August 1995 18:1187-1190; doi:10.2337/diacare.18.8.1187
Accuracy of Self-Monitoring Blood Glucose Meters in a High Humidity, High Temperature Summer Camp Setting Diabetes Care August 1995 18:1200-1201; doi:10.2337/diacare.18.8.1200
Rubin, Eugene H
Effects of Alprazolam on Glucose Regulation in Diabetes: Results of double-blind, placebo-controlled trial Diabetes Care August 1995 18:1133-1139; doi:10.2337/diacare.18.8.1133
Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM): Results of the feasibility
trial Diabetes Care August 1995 18:1113-1123; doi:10.2337/diacare.18.8.1113
Accuracy of Self-Monitoring Blood Glucose Meters in a High Humidity, High Temperature Summer Camp Setting Diabetes Care August 1995 18:1200-1201; doi:10.2337/diacare.18.8.1200
Schmelzer, James D
Lipoic Acid Improves Nerve Blood Flow, Reduces Oxidative Stress, and Improves Distal Nerve Conduction in Experimental Diabetic
Neuropathy Diabetes Care August 1995 18:1160-1167; doi:10.2337/diacare.18.8.1160
Physician and Patient Prevention Practices in NIDDM in a Large Urban Managed-Care Organization Diabetes Care August 1995 18:1124-1132; doi:10.2337/diacare.18.8.1124
Grapefruit Juice in Alloxan-Induced Diabetes in Rabbits Diabetes Care August 1995 18:1199; doi:10.2337/diacare.18.8.1199a
Silverstein, Janet H
Accuracy of Self-Monitoring Blood Glucose Meters in a High Humidity, High Temperature Summer Camp Setting Diabetes Care August 1995 18:1200-1201; doi:10.2337/diacare.18.8.1200
Stengård, Jari
Dietary Factors Determining Diabetes and Impaired Glucose Tolerance: A 20-year follow-up of the Finnish and Dutch cohorts
of the Seven Countries Study Diabetes Care August 1995 18:1104-1112; doi:10.2337/diacare.18.8.1104
Serum Lipids and Lipoprotein(a) Concentrations in Chinese NIDDM Patients: Relation to metabolic control Diabetes Care August 1995 18:1191-1194; doi:10.2337/diacare.18.8.1191
High Prevalence of Diabetic Retinopathy and Nephropathy in Polynesians of Western Samoa Diabetes Care August 1995 18:1140-1149; doi:10.2337/diacare.18.8.1140
High Prevalence of Diabetic Retinopathy and Nephropathy in Polynesians of Western Samoa Diabetes Care August 1995 18:1140-1149; doi:10.2337/diacare.18.8.1140
Local Reaction Secondary to Insulin Injection: A potential role for latex antigens in insulin vials and syringes Diabetes Care August 1995 18:1195-1197; doi:10.2337/diacare.18.8.1195
Dietary Factors Determining Diabetes and Impaired Glucose Tolerance: A 20-year follow-up of the Finnish and Dutch cohorts
of the Seven Countries Study Diabetes Care August 1995 18:1104-1112; doi:10.2337/diacare.18.8.1104
Local Reaction Secondary to Insulin Injection: A potential role for latex antigens in insulin vials and syringes Diabetes Care August 1995 18:1195-1197; doi:10.2337/diacare.18.8.1195
Serial Changes in the Prevalence of Islet Cell Antibodies and Islet Cell Antibody Titer in Children With IDDM of Abrupt or
Slow Onset Diabetes Care August 1995 18:1095-1099; doi:10.2337/diacare.18.8.1095
Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM): Results of the feasibility
trial Diabetes Care August 1995 18:1113-1123; doi:10.2337/diacare.18.8.1113
Dietary Factors Determining Diabetes and Impaired Glucose Tolerance: A 20-year follow-up of the Finnish and Dutch cohorts
of the Seven Countries Study Diabetes Care August 1995 18:1104-1112; doi:10.2337/diacare.18.8.1104
Serum Lipids and Lipoprotein(a) Concentrations in Chinese NIDDM Patients: Relation to metabolic control Diabetes Care August 1995 18:1191-1194; doi:10.2337/diacare.18.8.1191
1,5-Anhydro-D-glucitol Evaluates Daily Glycemic Excursions in Well-Controlled NIDDM Diabetes Care August 1995 18:1156-1159; doi:10.2337/diacare.18.8.1156
Physician and Patient Prevention Practices in NIDDM in a Large Urban Managed-Care Organization Diabetes Care August 1995 18:1124-1132; doi:10.2337/diacare.18.8.1124
High Prevalence of Diabetic Retinopathy and Nephropathy in Polynesians of Western Samoa Diabetes Care August 1995 18:1140-1149; doi:10.2337/diacare.18.8.1140